Core Insights - WeightWatchers has announced a pharmacy integration with Gifthealth to enhance access to Zepbound® for its clinic members [1][2] - The integration aims to streamline the fulfillment process and improve medication visibility for eligible members [2][3] Company Overview - WeightWatchers is a leader in science-backed weight management, providing a holistic model of care that includes clinical interventions and community support [4] - The company has been transforming lives for over 60 years, empowering millions of members to build healthy habits [4] Integration Details - The integration with Gifthealth allows for real-time prescription tracking and streamlined access to Zepbound® vials for self-pay patients without insurance [2][3] - Zepbound® usage among WeightWatchers Clinic members has increased significantly, with 33% currently using it and prescriptions for Zepbound vials rising over 100% recently [3] Clinical Impact - A study of 3,260 WeightWatchers Clinic patients showed an average weight loss of 21% at 12 months, indicating the effectiveness of combining GLP-1 medications like Zepbound with WeightWatchers' lifestyle support [3]

WW International, Inc. (NASDAQ:WW) Q4 2024 Earnings Conference Call February 27, 2025 5:00 PM ET Company Participants David Helderman - Director, Investor Relations Tara Comonte - President & Chief Executive Officer Felicia DellaFortuna - Chief Financial Officer Donna Boyer - Chief Product Officer Conference Call Participants Nathan Feather - Morgan Stanley Michael Lasser - UBS Alex Fuhrman - Craig-Hallum Capital Group Operator Good day, and welcome to the WeightWatchers Fourth Quarter and Full Year 2024 Re ...